SCHEMBL31500547

SCHEMBL31500547

NC(=O)Cc1ccc(SC(F)(F)F)cc1Cl

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.40
HTT P42858 2/20 0.40
MAPT P10636 1/20 0.40
TSHR P16473 1/20 0.40
MAPK1 P28482 1/20 0.40
KIF11 P52732 1/20 0.40
PTPRZ1 P23471 2/20 0.39
TDP1 Q9NUW8 2/20 0.37
KDM4E B2RXH2 1/20 0.37
ALDH1A1 P00352 1/20 0.37
KCNK2 O95069 2/20 0.36
KCNK10 P57789 2/20 0.36
ICMT O60725 1/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
EPHX1 P07099 1/20 0.33
KCNH2 Q12809 1/20 0.33
PPARG P37231 1/20 0.33
PPARA Q07869 1/20 0.33
PTPN1 P18031 1/20 0.33
NPC1 O15118 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9799086 0.77 KDM4E (0.39) LMNAHTTMAPTTSHRMAPK1
SCHEMBL31434971 0.76 DAO (0.46) LMNAMAPTALDH1A1ICMT
Trifluoroacetic Acid SCHEMBL6435984 0.74 TP53 (0.48) LMNAHTTTDP1L3MBTL1EPHX1
SCHEMBL1395757 0.74 ALDH1A1 (0.44) MAPTMAPK1KDM4EALDH1A1ICMT
SCHEMBL29718887 0.74 ALDH1A1 (0.44) MAPTMAPK1KDM4EALDH1A1ICMT
SCHEMBL9108524 0.74 PTPRZ1 (0.61) LMNAHTTKIF11PTPRZ1TDP1
SCHEMBL29718886 0.73 L3MBTL1 (0.55) HTTTDP1ALDH1A1L3MBTL1EPHX1
SCHEMBL260323 0.73 L3MBTL1 (0.55) HTTTDP1ALDH1A1L3MBTL1EPHX1
SCHEMBL12986139 0.72 LMNA (0.42) LMNAHTTMAPTTSHRMAPK1
SCHEMBL5724002 0.72 CA2 (0.48) TDP1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025087274-A1 AZABICYCLO DERIVATIVE AND PREPARATION METHOD THEREFOR, AND USE 浙江海正药业股份有限公司 2025-05-01 WO disclosed